London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel (Jeremy Kahn/Fortune)
Culture Index
Score Breakdown
Relevance
14/25
Freshness
25/25
Authority
25/20
Brand Signal
11/15
Depth
4/15
5-Axis Cultural Radar
Jeremy Kahn / Fortune : London-based Perceptic, which says its end-to-end AI platform for drug development is being used by top pharmaceuticals, raised a $12M seed led by Accel — A trio of former Palantir executives who helped spearhead that company's Life Sciences practice have founded a startup called Perceptic …
